Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2–associated encephalitis
Marta Bodro, Yaroslau Compta, Laura Llansó, Diana Esteller, Antonio Doncel-Moriano, Alex Mesa, Alejandro Rodríguez, Jordi Sarto, Eugenia Martínez‐Hernández, Alexandru Vlagea, Natalia Egri, Xavier Filella, Manuel Morales‐Ruiz, Jordi Yagüe, Àlex Soriano, Francesc Graus, Felipe García
Abstract
A national outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 in Wuhan, China, rapidly evolving to the coronavirus disease 2019 (COVID-19) pandemic. Neurologic complications of COVID-19 include headache, confusion, hyposmia, and dysgeusia,[1][1] with
Topics & Concepts
HyposmiaDysgeusiaMedicineOutbreakPandemicCoronavirus disease 2019 (COVID-19)CoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Anosmia2019-20 coronavirus outbreakEncephalitisVirologyBetacoronavirusConfusionDiseasePediatricsImmunologyInternal medicineInfectious disease (medical specialty)VirusPsychologyPsychoanalysisAdverse effectLong-Term Effects of COVID-19COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research